Literature DB >> 32995177

Acute Pulmonary Injury after Inhalation of Free-Base Cocaine: A Case Report.

Laura J Bontempo1, Phillip D Magidson1, Bryan D Hayes1, Joseph P Martinez1.   

Abstract

INTRODUCTION: Many patients presenting to urban emergency departments (EDs) have chief complaints directly related to the use of illicit drugs. Given the reluctance of patients to admit to their use of cocaine, it is important for the emergency medicine provider (EMP) to recognize key epidemiologic principles as well as features of the history, physical examination, and diagnostic studies that suggest the sequelae of cocaine abuse. CASE
PRESENTATION: We describe our assessment of an otherwise healthy 47-year-old man with the acute onset of pleuritic chest pain accompanied by hypoxia, radiographic evidence of diffuse alveolar hemorrhage (DAH), and an elevated creatine phosphokinase (CPK) level. The patient vehemently denied active cocaine abuse. No clear pulmonary, cardiac, or infectious explanations for his signs and symptoms were readily apparent. Ultimately, after further workup and urine toxicology screening, the cause of this patient's chest pain and hypoxia was determined to be DAH related to his recent inhalation of crack cocaine. The patient was treated with systemic corticosteroids and improved.
CONCLUSION: Nearly 41% of patients who present to the ED because of complications of inhaled cocaine use are experiencing pleuritic chest pain, and more than half have an elevated CPK concentration. As many as 40% of these patients deny using the drug when asked. These data are important for EMPs to know when formulating a differential diagnosis for patients presenting with pleuritic chest discomfort.
Copyright © 2017 by Taiwan Society of Emergency Medicine & Ainosco Press. All Rights Reserved.

Entities:  

Keywords:  chest pain; cocaine; inhalation injury; pulmonary disease

Year:  2017        PMID: 32995177      PMCID: PMC7517974          DOI: 10.6705/j.jacme.2017.0702.007

Source DB:  PubMed          Journal:  J Acute Med        ISSN: 2211-5587


  15 in total

1.  New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse.

Authors:  H H Osborn; M Tang; K Bradley; B R Duncan
Journal:  Acad Emerg Med       Date:  1997-07       Impact factor: 3.451

Review 2.  Cocaine intoxication.

Authors:  Janice L Zimmerman
Journal:  Crit Care Clin       Date:  2012-08-30       Impact factor: 3.598

3.  Respiratory effects of cocaine "freebasing" among habitual users of marijuana with or without tobacco.

Authors:  D P Tashkin; M S Simmons; A H Coulson; V A Clark; H Gong
Journal:  Chest       Date:  1987-10       Impact factor: 9.410

4.  Creatine phosphokinase elevation in patients presenting to the emergency department with cocaine-related complaints.

Authors:  F L Counselman; E W McLaughlin; E M Kardon; A S Bhambhani-Bhavnani
Journal:  Am J Emerg Med       Date:  1997-05       Impact factor: 2.469

5.  Stress system changes associated with marijuana dependence may increase craving for alcohol and cocaine.

Authors:  Helen C Fox; Keri L Tuit; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2012-12-28       Impact factor: 1.672

6.  Pulmonary status of habitual cocaine smokers.

Authors:  D P Tashkin; M E Khalsa; D Gorelick; P Chang; M S Simmons; A H Coulson; H Gong
Journal:  Am Rev Respir Dis       Date:  1992-01

7.  Nonfatal pulmonary edema after "freebase" cocaine smoking.

Authors:  R A Cucco; O H Yoo; L Cregler; J C Chang
Journal:  Am Rev Respir Dis       Date:  1987-07

8.  Cocaine induced eosinophilic lung disease.

Authors:  P I Oh; M S Balter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

Review 9.  Pulmonary complications from cocaine and cocaine-based substances: imaging manifestations.

Authors:  Carlos S Restrepo; Jorge A Carrillo; Santiago Martínez; Paulina Ojeda; Aura L Rivera; Ami Hatta
Journal:  Radiographics       Date:  2007 Jul-Aug       Impact factor: 5.333

10.  Chest pain associated with cocaine: an assessment of prevalence in suburban and urban emergency departments.

Authors:  J E Hollander; K H Todd; G Green; K L Heilpern; D J Karras; A J Singer; G X Brogan; J P Funk; J B Strahan
Journal:  Ann Emerg Med       Date:  1995-12       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.